Mortality of children with sickle cell disease: A population study

Jornal de Pediatria

Volumn 86, Issue 4, 2010, Pages 279-284

  Fernandes, Ana Paula Pinheiro Chagas ^a   Januário, José Nélio ^a   Cangussu, Camila Blanco ^a   De Macedo, Daniela Lino ^a   Viana, Marcos Borato ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anemia; Health services; Mortality; Sickle cell; Socioeconomic factors

Indexed keywords

ARTICLE; BRAZIL; CAUSE OF DEATH; CHILD; CLINICAL STUDY; CONSULTATION; CONTROLLED STUDY; DEATH CERTIFICATE; EPIDEMIOLOGICAL DATA; FEMALE; GENOTYPE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NEWBORN; NEWBORN SCREENING; POPULATION RESEARCH; PROBABILITY; SICKLE CELL ANEMIA; THALASSEMIA;

ANEMIA, SICKLE CELL; BRAZIL; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; SURVIVAL RATE;

EID: 77955856956     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.2005     Document Type: Article

References (30)

1. Serjeant GR. Sickle cell disease. 2nd ed. Oxford: Oxford University Press; 1992.
2. Cançado RD, Jesus JA. A doença falciforme no Brasil. Rev Bras Hematol Hemoter. 2007;29:204-6.
3. Januario J. Incidência da doença falciforme em um milhão de nascidos vivos em Minas Gerais (1998-2001) [dissertaç ão]. Belo Horizonte: Universidade Federal de Minas Gerais; 2002.
4. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics. 1989;84:500-8.
5. Serjeant GR. Natural history and determinants of clinical severity of sickle cell disease. Curr Opin Hematol. 1995;2:103-8.
6. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 1995;311:1600-2.
7. Koko J, Dufillot D, M'Ba-Meyo J, Gahouma D, Kani F. Mortality of children with sickle cell disease in a pediatric department in Central Africa. Arch Pediatr. 1998;5:965-9.
8. Thomas C, Lemerle S, Bernaudin F, Feingold J, Guillou-Bataille M, Reinert P. Sickle cell anemia: study of the pediatric mortality in Ile de France from 1985 to 1992. Arch Pediatr. 1996;3:445-51.
9. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-44.
10. Bainbridge R, Higgs DR, Maude GH, Serjeant GR. Clinical presentation of homozygous sickle cell disease. J Pediatr. 1985;106:881-5.
11. Powars D, Chan LS, Schroeder WA. The variable expression of sickle cell disease is genetically determined. Semin Hematol. 1990;27:360-76.
12. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749-55.
13. Zarkowsky HS, Gallagher D, Gill FM, Wang WC, Falletta JM, Lande WM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986;109:579-85.
14. Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr. 2009;154:541-5.
15. Scott RB. Health care priority and sickle cell anemia. JAMA. 1970;214:731-4.
16. Thomas AN, Pattison C, Serjeant GR. Causes of death in sicklecell disease in Jamaica. Br Med J. 1982;285:633-5.
17. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123:359-65.
18. Seeler RA. Deaths in children with sickle cell anemia. A clinical analysis of 19 fatal instances in Chicago. Clin Pediatr (Phila). 1972;11:634-7.
19. Diggs L. Anatomic lesions in sickle cell disease. In: Abramson H, Bertles JH, Wethers D, editors. Sickle cell disease: diagnosis, management, education and research. Saint Louis: CV Mosby; 1973. p. 189-229.
20. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83-9.
21. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995;86:776-83.
22. Rogers DW, Clarke JM, Cupidore L, Ramlal AM, Sparke BR, Serjeant GR. Early deaths in Jamaican children with sickle cell disease. Br Med J. 1978;1:1515-6.
23. Shankar SM, Arbogast PG, Mitchel E, Cooper WO, Wang WC, Griffin MR. Medical care utilization and mortality in sickle cell disease: a population-based study. Am J Hematol. 2005;80:262-70.
24. Centers for Disease Control and Prevention (CDC). Mortality among children with sickle cell disease identified by newborn screening during 1990-1994 - California, Illinois, and New York. MMWR Morb Mortal Wkly Rep. 1998;47:169-72.
25. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol. 1991;44:459-63.
26. Resende PV, Viana MB, Murao M, Chaves AC, Ribeiro AC. Acute splenic sequestration in a cohort of children with sickle cell anemia. J Pediatr (RJ). 2009;85:163-9.
27. Van-Dunem JC, Alves JG, Bernardino L, Figueiroa JN, Braga C, Nascimento Mde L, et al. Factors associated with sickle cell disease mortality among hospitalized Angolan children and adolescents. West Afr J Med. 2007;26:269-73.
28. Programa das Nações Unidas para o Desenvolvimento. Atlas do Desenvolvimento Humano no Brasil. Brasília: PNUD-Brasil; 2002. http://www.pnud.org.br/atlas. Access: 23/05/2006.
29. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103:4023-7.
30. Bitarães EL, Oliveira BM, Viana MB. Compliance with antibiotic prophylaxis in children with sickle cell anemia: a prospective study. J Pediatr (Rio J). 2008;84:316-22.